Capstone Therapeutics (NASDAQ:CAPS) & Rectitude (NASDAQ:RECT) Head to Head Survey

Rectitude (NASDAQ:RECT) and Capstone Therapeutics (NASDAQ:CAPS) are both small-cap industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

Risk and Volatility

Rectitude has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, Capstone Therapeutics has a beta of -1.52, suggesting that its stock price is 252% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Rectitude and Capstone Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rectitude	1	0	0	0	1.00
Capstone Therapeutics	1	0	0	0	1.00

Earnings & Valuation

This table compares Rectitude and Capstone Therapeutics”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rectitude	$39.74 million	0.45	$2.78 million	N/A	N/A
Capstone Therapeutics	$48.11 million	0.09	-$21.23 million	($3.37)	-0.08

Rectitude has higher earnings, but lower revenue than Capstone Therapeutics.

Insider and Institutional Ownership

2.5% of Capstone Therapeutics shares are held by institutional investors. 39.3% of Capstone Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Rectitude and Capstone Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rectitude	N/A	N/A	N/A
Capstone Therapeutics	-41.26%	-114.15%	-39.74%

Summary

Rectitude beats Capstone Therapeutics on 6 of the 9 factors compared between the two stocks.

About Rectitude

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, gloves, safety footwear, personal fall arrest systems, portable fire extinguishers and traffic products. The Company also offers auxiliary products such as industrial hardware tools and electrical hardware required for construction sites. Rectitude Holdings Ltd is based in SINGAPORE.

About Capstone Therapeutics

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.